IGNE fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
IGENE Biotechnology, Inc. engages in the research, development, production, and commercialization of specialty ingredients for human and animal nutrition. It offers feed ingredients and nutraceutical products that includes astaxanthin. The company was founded by Robert Austin Milch and William T. Hall on October 27, 1981 and is headquartered in Columbia, MD.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
IGNE does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company